Related Experiment Video
Updated: Sep 29, 2025
09:16
Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
7.7K
Epigenetic and Transcriptional Regulation of Innate Immunity in Cancer
Chuan Chen1, Na Man1, Fan Liu1,2
1Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida.
Cancer Research
|March 23, 2022
Summary
Innate immune cells detect tumors through pattern-recognition receptors. Epigenetic regulation of these pathways offers new avenues for cancer immunotherapy.
Area of Science:
- Immunology
- Oncology
- Epigenetics
Background:
- Innate immune cells, like those recognizing tumor cells via pattern-recognition receptors (e.g., Toll-like receptors, nucleotide-binding and oligomerization domain-like receptors), are crucial in cancer surveillance.
- Epigenetic mechanisms finely tune innate immune signaling pathways, and disruptions in hematopoiesis can lead to altered immunity and cancer development.
Purpose of the Study:
- To review the epigenetic and transcriptional mechanisms governing innate immune signaling in cancer.
- To explore novel therapeutic strategies targeting innate immune cells and signaling for cancer control.
Main Methods:
- Literature review focusing on epigenetic regulation of innate immunity in cancer.
- Analysis of transcriptional mechanisms in anti-tumor immune responses.
- Discussion of emerging immunotherapies targeting innate immune pathways.
Main Results:
- Innate immune signaling pathways are intricately regulated by epigenetic mechanisms.
- Dysregulated hematopoiesis impacts immune surveillance and cancer progression.
- Targeting innate immune signaling presents promising opportunities for next-generation cancer immunotherapy.
Conclusions:
- Understanding the epigenetic and transcriptional control of innate immunity is key to cancer control.
- Exploiting innate immune signaling pathways offers a promising frontier for novel cancer immunotherapies.
Related Concept Videos
01:37Epigenetic Regulation
3.2K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.2K
02:53Adaptive Mechanisms in Cancer Cells
6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
02:26NF-κB-dependent Signaling Pathway
7.9K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.9K
01:31The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
02:23Master Transcription Regulators
7.2K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.2K
01:06Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K